SCHEMBL8218552

SCHEMBL8218552

CCOC(=O)c1cc2ncc(C)cn2n1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM5 P41594 1/20 0.46
KDM4E B2RXH2 10/20 0.46
RAB9A P51151 5/20 0.46
NPC1 O15118 3/20 0.46
RXFP1 Q9HBX9 1/20 0.46
POLB P06746 2/20 0.46
KMT2A Q03164 3/20 0.45
ESR2 Q92731 2/20 0.44
ESR1 P03372 1/20 0.44
GAA P10253 3/20 0.44
GLA P06280 2/20 0.44
RECQL P46063 1/20 0.43
ALDH1A1 P00352 2/20 0.43
HPGD P15428 2/20 0.43
MEN1 O00255 1/20 0.42
CYP1A2 P05177 1/20 0.41
LMNA P02545 1/20 0.40
NR4A1 P22736 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
TDP1 Q9NUW8 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12942831 0.86 ESR2 (0.43) KDM4ERAB9ANPC1RXFP1POLB
SCHEMBL1080204 0.86 RECQL (0.59) GRM5KDM4ERAB9ANPC1RXFP1
SCHEMBL1077910 0.86 LMNA (0.49) GRM5KDM4ERAB9ANPC1RXFP1
SCHEMBL17460385 0.86 KDM4E (0.47) KDM4ERAB9ANPC1RXFP1POLB
SCHEMBL21639018 0.85 LMNA (0.47) KDM4ERAB9ANPC1RXFP1POLB
SCHEMBL25097587 0.84 RAB9A (0.46) KDM4ERAB9ANPC1RXFP1POLB
SCHEMBL21639146 0.82 LMNA (0.44) KDM4ERAB9ANPC1RXFP1POLB
SCHEMBL8214427 0.80 KDM4E (0.60) GRM5KDM4ERAB9ANPC1POLB
SCHEMBL25074769 0.80 GRM5 (0.51) GRM5KDM4ERAB9ANPC1POLB
SCHEMBL21689285 0.80 KMT2A (0.41) KDM4ERAB9ANPC1RXFP1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024137329-A1 METHODS FOR THE SYNTHESIS OF COMPLEMENT FACTOR D INHIBITORS AND INTERMEDIATES THEREOF ALEXION PHARMACEUTICALS, INC. (US) 2024-06-27 WO disclosed
WO-2023114198-A2 METHODS FOR THE SYNTHESIS OF COMPLEMENT FACTOR D INHIBITORS ALEXION PHARMACEUTICALS, INC. (US) 2023-06-22 WO disclosed
WO-2023114200-A2 METHODS FOR THE SYNTHESIS OF COMPLEMENT FACTOR D INHIBITORS AND INTERMEDIATES THEREOF ALEXION PHARMACEUTICALS, INC. (US) 2023-06-22 WO disclosed
EP-2054416-B1 SUBSTITUTED PYRAZOLOPYRIMIDINES, A PROCESS FOR THEIR PREPARATION AND THEIR USE AS MEDICINE MERZ PHARMA GMBH & CO KGAA (DE) 2011-01-05 EP disclosed
WO-2008015269-A1 SUBSTITUTED PYRAZOLOPYRIMIDINES, A PROCESS FOR THEIR PREPARATION AND THEIR USE AS MEDICINE MERZ PHARMA GMBH & CO. KGAA (DE) 2008-02-07 WO disclosed
WO-2008015270-A1 PYRAZOLOPYRIMIDINES, A PROCESS FOR THEIR PREPARATION AND THEIR USE AS MEDICINE MERZ PHARMA GMBH & CO. KGAA (DE) 2008-02-07 WO disclosed